| Date | Title | Description | Source |
| 30.04.2024 | BERGENBIO ASA: BOARD APPROVAL OF 2023 ANNUAL FINANCIAL STATE... | BERGENBIO ASA: BOARD APPROVAL OF 2023 ANNUAL FINANCIAL STATEMENT AND ANNUAL REPORT 2023
Tue, Apr 30,... | news.cisio... |
| 30.04.2024 | BerGenBio ASA: Notice of Annual General Meeting | BerGenBio ASA: Notice of Annual General Meeting
Tue, Apr 30, 2024 14:00 CET Report this content
Berg... | news.cisio... |
| 25.04.2024 | BerGenBio ASA: New share capital registered | BerGenBio ASA: New share capital registered
Thu, Apr 25, 2024 12:55 CET Report this content
Bergen, ... | news.cisio... |
| 17.04.2024 | BerGenBio ASA: Resolution to increase the share capital for ... | BerGenBio ASA: Resolution to increase the share capital for settlement of underwriting commission
We... | news.cisio... |
| 16.04.2024 | BerGenBio ASA: Final results for the last exercise period fo... | BerGenBio ASA: Final results for the last exercise period for warrants issued in connection with rig... | news.cisio... |
| 15.04.2024 | BerGenBio ASA: Last day of the last exercise period for warr... | BerGenBio ASA: Last day of the last exercise period for warrants issued in connection with rights is... | news.cisio... |
| 15.04.2024 | BerGenBio ASA: Mandatory notification of trade by primary in... | BerGenBio ASA: Mandatory notification of trade by primary insiders and close associates
Mon, Apr 15,... | news.cisio... |
| 08.04.2024 | BerGenBio ASA: Last day of trading in warrants | BerGenBio ASA: Last day of trading in warrants
Mon, Apr 08, 2024 07:15 CET Report this content
NOT F... | news.cisio... |
| 03.04.2024 | BerGenBio ASA: Information about the last exercise period fo... | BerGenBio ASA: Information about the last exercise period for Warrants issued in connection with rig... | news.cisio... |
| 02.04.2024 | BerGenBio ASA secures underwriting of NOK 118 million gross ... | BerGenBio ASA secures underwriting of NOK 118 million gross proceeds representing minimum 80% exerci... | news.cisio... |
| 02.04.2024 | BerGenBio ASA: Commencement of the last exercise period for ... | BerGenBio ASA: Commencement of the last exercise period for warrants issued in connection with right... | news.cisio... |
| 27.03.2024 | BerGenBio ASA: Exercise price in the last exercise period fo... | BerGenBio ASA: Exercise price in the last exercise period for warrants issued in connection with rig... | news.cisio... |
| 20.03.2024 | BerGenBio Announces Initiation of Phase 2a in First Line Non... | BerGenBio Announces Initiation of Phase 2a in First Line Non-Small Lung Cancer Patients with a STK11... | news.cisio... |
| 04.03.2024 | BerGenBio to Participate in Carnegie Nordic Healthcare Semin... | BerGenBio to Participate in Carnegie Nordic Healthcare Seminar
Mon, Mar 04, 2024 07:00 CET Report th... | news.cisio... |
| 19.02.2024 | BerGenBio ASA – Approval and publication of a prospectus sup... | BerGenBio ASA – Approval and publication of a prospectus supplement
Mon, Feb 19, 2024 17:58 CET Repo... | news.cisio... |
| 14.02.2024 | BerGenBio’s Fourth Quarter 2023 Results: Focused Strategy Ga... | BerGenBio’s Fourth Quarter 2023 Results: Focused Strategy Gathers Momentum
Wed, Feb 14, 2024 07:00 C... | news.cisio... |
| 07.02.2024 | BerGenBio Announces New Preclinical Data Indicating Broadene... | BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Sev... | news.cisio... |
| 06.02.2024 | BerGenBio ASA: Invitation to fourth quarter 2023 results web... | BerGenBio ASA: Invitation to fourth quarter 2023 results webcast
Tue, Feb 06, 2024 07:00 CET Report ... | news.cisio... |
| 15.12.2023 | BerGenBio announces closure of EU-SolidAct bemcentinib study... | BerGenBio announces closure of EU-SolidAct bemcentinib study arm in hospitalized COVID-19 patients
F... | news.cisio... |
| 12.12.2023 | BerGenBio to Present at DNB Nordic Healthcare Conference | BerGenBio to Present at DNB Nordic Healthcare Conference
Tue, Dec 12, 2023 07:00 CET Report this con... | news.cisio... |
| 11.12.2023 | BerGenBio Announces Final Bemcentinib Phase 2 Data in AML an... | BerGenBio Announces Final Bemcentinib Phase 2 Data in AML and MDS Presented at the 2023 ASH Meeting
... | news.cisio... |
| 08.12.2023 | BerGenBio ASA - New share capital registered | BerGenBio ASA - New share capital registered
Fri, Dec 08, 2023 08:32 CET Report this content
Bergen ... | news.cisio... |
| 08.12.2023 | BerGenBio ASA: Grant of share options | BerGenBio ASA: Grant of share options
Fri, Dec 08, 2023 18:10 CET Report this content
Bergen, Norway... | news.cisio... |
| 07.12.2023 | BerGenBio ASA: Approval and publication of prospectus | BerGenBio ASA: Approval and publication of prospectus
Thu, Dec 07, 2023 14:05 CET Report this conten... | news.cisio... |
| 07.12.2023 | BerGenBio ASA – Updated timeline for delivery of new shares... | BerGenBio ASA – Updated timeline for delivery of new shares
Thu, Dec 07, 2023 10:47 CET Report this ... | news.cisio... |
| 30.11.2023 | BerGenBio ASA – Final results for the first exercise period ... | BerGenBio ASA – Final results for the first exercise period for warrants issued in connection with r... | news.cisio... |
| 29.11.2023 | BerGenBio ASA – Preliminary results for the first exercise p... | BerGenBio ASA – Preliminary results for the first exercise period for warrants issued in connection ... | news.cisio... |
| 28.11.2023 | BerGenBio ASA – Last day of the first exercise period for wa... | BerGenBio ASA – Last day of the first exercise period for warrants issued in connection with rights ... | news.cisio... |
| 24.11.2023 | BerGenBio ASA – Information about the first exercise period ... | BerGenBio ASA – Information about the first exercise period for warrants issued in connection with r... | news.cisio... |
| 15.11.2023 | BerGenBio ASA - Commencement of the first exercise period fo... | BerGenBio ASA - Commencement of the first exercise period for warrants issued in connection with rig... | news.cisio... |
| 14.11.2023 | BerGenBio Reports Third Quarter 2023 Financial Results | BerGenBio Reports Third Quarter 2023 Financial Results
Tue, Nov 14, 2023 07:00 CET Report this conte... | news.cisio... |
| 06.11.2023 | BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC | BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC
Mon, Nov 06, 2023 07:00 CET Report this... | news.cisio... |
| 06.11.2023 | BerGenBio ASA: Invitation to third quarter 2023 results webc... | BerGenBio ASA: Invitation to third quarter 2023 results webcast
Mon, Nov 06, 2023 12:00 CET Report t... | news.cisio... |
| 02.11.2023 | BerGenBio Announces Poster Presentation at Upcoming ASH Meet... | BerGenBio Announces Poster Presentation at Upcoming ASH Meeting
Thu, Nov 02, 2023 14:00 CET Report t... | news.cisio... |
| 31.10.2023 | BerGenBio Announces Poster Presentation at Upcoming SITC Mee... | BerGenBio Announces Poster Presentation at Upcoming SITC Meeting
Tue, Oct 31, 2023 14:00 CET Report ... | news.cisio... |
| 23.10.2023 | New Data on BerGenBio’s Selective AXL Inhibitor Bemcentinib ... | New Data on BerGenBio’s Selective AXL Inhibitor Bemcentinib Released Today at 2023 ESMO Meeting
Mon,... | news.cisio... |
| 16.10.2023 | Additional data on BerGenBio’s selective AXL inhibitor bemce... | Additional data on BerGenBio’s selective AXL inhibitor bemcentinib to be presented at the 2023 ESMO ... | news.cisio... |
| 11.09.2023 | BerGenBio to Present Company Update at H.C. Wainright Annual... | BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference
Mon, Sep 1... | news.cisio... |
| 23.08.2023 | BerGenBio Reports Second Quarter 2023 Financial Results | BerGenBio Reports Second Quarter 2023 Financial Results
Wed, Aug 23, 2023 07:00 CET Report this cont... | news.cisio... |
| 22.08.2023 | BerGenBio announces clinical data presentations highlighting... | BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhib... | news.cisio... |
| 16.08.2023 | BerGenBio ASA: Invitation to second quarter and half year 20... | BerGenBio ASA: Invitation to second quarter and half year 2023 results webcast
Wed, Aug 16, 2023 07:... | news.cisio... |
| 29.06.2023 | BerGenBio ASA: Share capital increase registered | BerGenBio ASA: Share capital increase registered
Thu, Jun 29, 2023 14:39 CET Report this content
Ber... | news.cisio... |
| 27.06.2023 | BerGenBio ASA: Resolution to increase the share capital for ... | BerGenBio ASA: Resolution to increase the share capital for settlement of underwriting commission
Tu... | news.cisio... |
| 23.06.2023 | BerGenBio ASA - Information about the Warrants issued in con... | BerGenBio ASA - Information about the Warrants issued in connection with the Rights Issue
Fri, Jun 2... | news.cisio... |
| 22.06.2023 | BerGenBio ASA - Correction, new share capital and warrants r... | BerGenBio ASA - Correction, new share capital and warrants registered
Thu, Jun 22, 2023 12:36 CET Re... | news.cisio... |
| 22.06.2023 | BerGenBio Reports First Quarter 2023 Financial Results and P... | BerGenBio Reports First Quarter 2023 Financial Results and Provides Business Update
Thu, Jun 22, 202... | news.cisio... |
| 22.06.2023 | BerGenBio ASA - New share capital and warrants registered | BerGenBio ASA - New share capital and warrants registered
Thu, Jun 22, 2023 11:36 CET Report this co... | news.cisio... |
| 19.06.2023 | BerGenBio ASA – Updated timeline for delivery of Offer Share... | BerGenBio ASA – Updated timeline for delivery of Offer Shares and Warrants in connection with the Ri... | news.cisio... |
| 14.06.2023 | BerGenBio ASA – Final results of the Rights Issue | BerGenBio ASA – Final results of the Rights Issue
Wed, Jun 14, 2023 13:30 CET Report this content
NO... | news.cisio... |
| 13.06.2023 | BerGenBio ASA – Preliminary results indicates an oversubscri... | BerGenBio ASA – Preliminary results indicates an oversubscribed Rights Issue of gross NOK 250 millio... | news.cisio... |
| 13.06.2023 | BerGenBio ASA – Last day of the Subscription Period in the R... | BerGenBio ASA – Last day of the Subscription Period in the Rights Issue
Tue, Jun 13, 2023 07:00 CET ... | news.cisio... |
| 07.06.2023 | BerGenBio ASA – Last day of trading in Subscription Rights | BerGenBio ASA – Last day of trading in Subscription Rights
Wed, Jun 07, 2023 07:00 CET Report this c... | news.cisio... |
| 05.06.2023 | BerGenBio Announces Data from Bemcentinib Trial in Mesotheli... | BerGenBio Announces Data from Bemcentinib Trial in Mesothelioma Presented at ASCO
Mon, Jun 05, 2023 ... | news.cisio... |
| 30.05.2023 | BerGenBio to Participate in Investor Webcast and Q&A | BerGenBio to Participate in Investor Webcast and Q&A
Tue, May 30, 2023 18:19 CET Report this con... | news.cisio... |
| 30.05.2023 | BerGenBio ASA - Commencement of the subscription period for ... | BerGenBio ASA - Commencement of the subscription period for the rights issue
Tue, May 30, 2023 07:00... | news.cisio... |
| 26.05.2023 | BerGenBio ASA: Approval and publication of prospectus for th... | BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue
Fri, May 26,... | news.cisio... |
| 25.05.2023 | BerGenBio Announces Abstracts Accepted for Presentation at 2... | BerGenBio Announces Abstracts Accepted for Presentation at 2023 ASCO
Thu, May 25, 2023 07:00 CET Rep... | news.cisio... |
| 22.05.2023 | BerGenBio ASA: Annual general meeting held | BerGenBio ASA: Annual general meeting held
Mon, May 22, 2023 18:01 CET Report this content
NOT FOR R... | news.cisio... |
| 20.05.2023 | BERGENBIO ASA – Terms of the partially underwritten rights i... | BERGENBIO ASA – Terms of the partially underwritten rights issue
Sat, May 20, 2023 12:00 CET Report ... | news.cisio... |
| 09.05.2023 | BerGenBio to hold business update conference call | BerGenBio to hold business update conference call
Tue, May 09, 2023 18:14 CET Report this content
- ... | news.cisio... |
| 28.04.2023 | BERGENBIO ASA: Board approval of 2022 Annual Financial State... | BERGENBIO ASA: Board approval of 2022 Annual Financial Statement and Annual Report 2022
Fri, Apr 28,... | news.cisio... |
| 28.04.2023 | BERGENBIO ASA: Notice of Annual General Meeting | BERGENBIO ASA: Notice of Annual General Meeting
Fri, Apr 28, 2023 15:00 CET Report this content
Berg... | news.cisio... |
| 18.04.2023 | BerGenBio Presents Data on STK11 Loss of Function and AXL Ac... | BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR
Tue, Apr 18, 2023 07:00... | news.cisio... |
| 28.03.2023 | BerGenBio to Present at Upcoming Scientific Conferences | BerGenBio to Present at Upcoming Scientific Conferences
Tue, Mar 28, 2023 08:00 CET Report this cont... | news.cisio... |
| 16.03.2023 | BerGenBio to Present at the Carnegie Nordic Healthcare Confe... | BerGenBio to Present at the Carnegie Nordic Healthcare Conference
Thu, Mar 16, 2023 07:00 CET Report... | news.cisio... |
| 16.02.2023 | BerGenBio Reports Fourth Quarter 2022 Financial Results and ... | BerGenBio Reports Fourth Quarter 2022 Financial Results and Provides Business Update
Thu, Feb 16, 20... | news.cisio... |
| 02.02.2023 | BerGenBio Announces the Establishment of Oncology Scientific... | BerGenBio Announces the Establishment of Oncology Scientific Advisory Board
Thu, Feb 02, 2023 07:00 ... | news.cisio... |
| 01.02.2023 | BerGenBio ASA: Invitation to fourth quarter 2022 results web... | BerGenBio ASA: Invitation to fourth quarter 2022 results webcast
Wed, Feb 01, 2023 07:00 CET Report ... | news.cisio... |
| 08.12.2022 | BerGenBio to present at DNB’s Nordic Healthcare Conference | BerGenBio to present at DNB’s Nordic Healthcare Conference
Thu, Dec 08, 2022 07:00 CET Report this c... | news.cisio... |
| 15.11.2022 | BerGenBio reports third quarter 2022 financial results and p... | BerGenBio reports third quarter 2022 financial results and provides business update
Tue, Nov 15, 202... | news.cisio... |
| 08.11.2022 | BerGenBio ASA: Invitation to third quarter 2022 results webc... | BerGenBio ASA: Invitation to third quarter 2022 results webcast
Tue, Nov 08, 2022 07:00 CET Report t... | news.cisio... |
| 07.09.2022 | BerGenBio to Present at Pareto Securities’ 13th Annual Healt... | BerGenBio to Present at Pareto Securities’ 13th Annual Healthcare Conference
Wed, Sep 07, 2022 07:00... | news.cisio... |
| 23.08.2022 | BerGenBio reports second quarter and half year 2022 financia... | BerGenBio reports second quarter and half year 2022 financial results and provides business update
T... | news.cisio... |
| 09.08.2022 | BERGENBIO ASA: Invitation to second quarter and half year 20... | BERGENBIO ASA: Invitation to second quarter and half year 2022 results webcast
Tue, Aug 09, 2022 07:... | news.cisio... |
| 16.06.2022 | BerGenBio - Mandatory notification of trade by Primary Insid... | BerGenBio - Mandatory notification of trade by Primary Insider
Thu, Jun 16, 2022 12:58 CET Report th... | news.cisio... |
| 06.06.2022 | BERGENBIO PRESENTS CLINICAL DATA ON BEMCENTINIB IN COMBINATI... | BERGENBIO PRESENTS CLINICAL DATA ON BEMCENTINIB IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH PREVI... | news.cisio... |
| 24.05.2022 | BERGENBIO ASA: RESULTS FOR THE FIRST QUARTER 2022 | BERGENBIO ASA: RESULTS FOR THE FIRST QUARTER 2022
Tue, May 24, 2022 07:00 CET Report this content
Be... | news.cisio... |
| 18.05.2022 | BERGENBIO ASA: INVITATION TO FIRST QUARTER 2022 RESULTS WEBC... | BERGENBIO ASA: INVITATION TO FIRST QUARTER 2022 RESULTS WEBCAST
Wed, May 18, 2022 07:00 CET Report t... | news.cisio... |
| 16.05.2022 | BERGENBIO TO PRESENT AT ABG SUNDAL COLLIER LIFE SCIENCE SUMM... | BERGENBIO TO PRESENT AT ABG SUNDAL COLLIER LIFE SCIENCE SUMMIT
Mon, May 16, 2022 07:00 CET Report th... | news.cisio... |
| 04.05.2022 | BerGenBio narrows R&D to focus on NSCLC and Covid-19;... | BerGenBio said it will prioritize its pipeline to focus on first-line non-small cell lung canc... | endpts.com... |
| 04.05.2022 | BERGENBIO ANNOUNCES LAUNCH OF BUSINESS STRATEGY FOCUSED ON N... | BERGENBIO ANNOUNCES LAUNCH OF BUSINESS STRATEGY FOCUSED ON NSCLC AND COVID-19
Wed, May 04, 2022 07:0... | news.cisio... |
| 28.04.2022 | BerGenBio ASA: Minutes from the Annual General Meeting | BerGenBio ASA: Minutes from the Annual General Meeting
Thu, Apr 28, 2022 11:28 CET Report this conte... | news.cisio... |
| 26.04.2022 | BERGENBIO ANNOUNCES COMPLETE DATA ANALYSIS OF ACCORD2 PHASE ... | BERGENBIO ANNOUNCES COMPLETE DATA ANALYSIS OF ACCORD2 PHASE II BEMCENTINIB STUDY IN HOSPITALIZED COV... | news.cisio... |
| 26.04.2022 | BERGENBIO TO PRESENT AT ARCTIC SECURITIES BIOTECH WEBINAR | BERGENBIO TO PRESENT AT ARCTIC SECURITIES BIOTECH WEBINAR
Tue, Apr 26, 2022 10:51 CET Report this co... | news.cisio... |
| 25.04.2022 | BERGENBIO PRESENTS BEMCENTINIB COVID-19 CLINICAL TRIAL DATA ... | BERGENBIO PRESENTS BEMCENTINIB COVID-19 CLINICAL TRIAL DATA AT ECCMID 2022
Mon, Apr 25, 2022 07:00 C... | news.cisio... |
| 11.04.2022 | BerGenBio strengthens its leadership team with appointment o... | BerGenBio strengthens its leadership team with appointment of Cristina Oliva as Chief Medical Office... | news.cisio... |
| 07.04.2022 | BERGENBIO ASA: BOARD APPROVAL OF 2021 ANNUAL FINANCIAL STATE... | BERGENBIO ASA: BOARD APPROVAL OF 2021 ANNUAL FINANCIAL STATEMENT AND ANNUAL REPORT 2021
Thu, Apr 07,... | news.cisio... |
| 07.04.2022 | BERGENBIO ASA: NOTICE OF ANNUAL GENERAL MEETING | BERGENBIO ASA: NOTICE OF ANNUAL GENERAL MEETING
Thu, Apr 07, 2022 15:00 CET Report this content
Berg... | news.cisio... |
| 17.03.2022 | BERGENBIO TO PRESENT AT CARNEGIE VIRTUAL NORDIC HEALTHCARE S... | BERGENBIO TO PRESENT AT CARNEGIE VIRTUAL NORDIC HEALTHCARE SEMINAR
Thu, Mar 17, 2022 08:00 CET Repor... | news.cisio... |
| 17.03.2022 | BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOU... | BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOURNAL INDICATING EFFICACY OF BEMCENTINIB ... | news.cisio... |
| 17.03.2022 | BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOU... | BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOURNAL INDICATING EFFICACY OF BEMCENTINIB ... | news.cisio... |
| 22.02.2022 | BerGenBio ASA: Share capital increase | BerGenBio ASA: Share capital increase
Tue, Feb 22, 2022 12:00 CET Report this content
Bergen, Norway... | news.cisio... |
| 16.02.2022 | BERGENBIO ASA: RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ... | BERGENBIO ASA: RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2021
Wed, Feb 16, 2022 07:00 CET Report ... | news.cisio... |
| 08.02.2022 | BERGENBIO ASA: INVITATION TO FOURTH QUARTER 2021 RESULTS WEB... | BERGENBIO ASA: INVITATION TO FOURTH QUARTER 2021 RESULTS WEBCAST
Tue, Feb 08, 2022 07:00 CET Report ... | news.cisio... |
| 27.01.2022 | BerGenBio and Oslo University Hospital Announce the AXL Inhi... | BerGenBio and Oslo University Hospital Announce the AXL Inhibitor Bemcentinib will be Studied in the... | news.cisio... |
| 10.01.2022 | BerGenBio - Mandatory notification of trade by Primary Insid... | BerGenBio - Mandatory notification of trade by Primary Insider Mon, Jan 10, 2022 19:52 CET
Bergen, N... | news.cisio... |
| 07.01.2022 | BERGENBIO - Mandatory notification of trade by Primary Insid... | BERGENBIO - Mandatory notification of trade by Primary Insider Fri, Jan 07, 2022 09:03 CET
Bergen, N... | news.cisio... |
| 07.01.2022 | BerGenBio - Mandatory notification of trade by Primary Insid... | BerGenBio - Mandatory notification of trade by Primary Insiders Fri, Jan 07, 2022 17:51 CET
Bergen, ... | news.cisio... |
| 06.01.2022 | BERGENBIO APPOINTS ANDERS TULLGREN AS CHAIRMAN OF BOARD | Bergen, Norway, 6 January 2022 - BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical compa... | marketscre... |
| 06.01.2022 | BerGenBio ASA: Extraordinary General Meeting held | Bergen, Norway, 6 January 2022 - BerGenBio ASA (OSE:BGBIO) announces that an extraordinary general m... | marketscre... |
